Leopoldo Naranjo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Leopoldo Naranjo has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Javier Casqueiro
Área de Microbiología, Facultad de Biología y Ciencias Ambientales, Universidad de León, León, Spain
7 shared publications Jose David Rosales Rangel
5 shared publications- Juan Francisco Martín
Área de Microbiología, Facultad de Ciencias Biológicas y Ambientales, Universidad de León, Campus de Vegazana, s/n, 24071 León, Spain
5 shared publications - Keyla M. Fuentes
Group of Colloidal and Interfacial Chemistry Applied to Nanomaterials and Formulations, Centro de Investigación en Materiales Avanzados, S. C. (CIMAV), Unidad Monterrey, Alianza Norte 202, Parque de Investigación e Innovación Tecnológica, Apodaca 66628, Mexico
5 shared publications - Beatriz Pernía
Facultad de Ciencias Naturales, Universidad de Guayaquil, Av. Raúl Gómez Lince s/n y Av. Juan Tanca Marengo, Guayaquil 090150, Ecuador
3 shared publications - Hector Urbina
Florida Department of Agriculture and Consumer Services (FDACS), Division of Plant Industry (DPI), Section of Plant Pathology, Gainesville, FL 32608, U.S.A.
3 shared publications
Latest Publications
- Open Access
- 4 March 2021
- Published by Pensoft Publishers in ARPHA Conference Abstracts
- Vol. 4, e65304
DNA-based biomonitoring in the tropics: Detection and control of Batrachochytrium dendrobatidis in Ecuadorian ecosystem
Batrachochytrium dendrobatidis (Bd) is a fungus that parasites vertebrates, and is associated with population declines worldwide in endemic amphibian species. As such, it is one of several invasive species which pose a serious threat to a variety of vertebrate hosts, in casu: amphibians. Detection of such invasive species is generally based on DNA-based methods where, for instance, swabs or tissue samples of candidate hosts are analysed for their presence. Any management strategy of these invasive species would greatly benefit from sensitive and rapid detection methods which can be applied at a large scale. The analysis of eDNA from the habitat of candidate host organisms may hold significant potential for this purpose. In this study, we compare the ability of eDNA from habitat samples with that of swab and/or tissue samples of candidate hosts to detect the presence of Bd in Ecuador. We collected individuals from the amphibians: Pristimantis (Anura: Craugastoridae), Rhinella (Anura: Bufonidae), Gastroteca (Anura: Hemiphractidae), from the endangered toad species of the genus Atelopus (Anura: Bufonidae) as well as water samples from different water bodies in Andean and coastal Ecuadorian areas. Samples were processed using a portable field molecular laboratory. Commercial primers for the internal transcribed spacer (ITS), in combination with a new set of primers designed from Bd sequences from tropical countries, were used. Positive PCR results from both types of samples were obtained within eight hours after sampling. Prevalence of BD was detected in eDNA, swab and tissue samples in four of the six ecosystems monitored -14 out of 26 water samples and 27 out of 43 amphibian of in total 12 species- including three endangered toad species (Atelopus balios, A. nanay, and the rediscovered A. bomolochos). Our results highlight the potential of eDNA-based monitoring to assess the presence and prevalence of Bd in Ecuadorian aquatic ecosystems, in accordance with the National Action Plan for the Conservation of Ecuadorian Amphibians. Furthermore, our field lab approach leads to reliable and fast results for the monitoring of invasive species in a tropical context of a pandemic.
- 4 March 2021
- Published by Pensoft Publishers in ARPHA Conference Abstracts
- Vol. 4, e65304
Open AccessDNA-based biomonitoring in the tropics: Detection and control of Batrachochytrium dendrobatidis in Ecuadorian ecosystem
Batrachochytrium dendrobatidis (Bd) is a fungus that parasites vertebrates, and is associated with population declines worldwide in endemic amphibian species. As such, it is one of several invasive species which pose a serious threat to a variety of vertebrate hosts, in casu: amphibians. Detection of such invasive species is generally based on DNA-based methods where, for instance, swabs or tissue samples of candidate hosts are analysed for their presence. Any management strategy of these invasive species would greatly benefit from sensitive and rapid detection methods which can be applied at a large scale. The analysis of eDNA from the habitat of candidate host organisms may hold significant potential for this purpose. In this study, we compare the ability of eDNA from habitat samples with that of swab and/or tissue samples of candidate hosts to detect the presence of Bd in Ecuador. We collected individuals from the amphibians: Pristimantis (Anura: Craugastoridae), Rhinella (Anura: Bufonidae), Gastroteca (Anura: Hemiphractidae), from the endangered toad species of the genus Atelopus (Anura: Bufonidae) as well as water samples from different water bodies in Andean and coastal Ecuadorian areas. Samples were processed using a portable field molecular laboratory. Commercial primers for the internal transcribed spacer (ITS), in combination with a new set of primers designed from Bd sequences from tropical countries, were used. Positive PCR results from both types of samples were obtained within eight hours after sampling. Prevalence of BD was detected in eDNA, swab and tissue samples in four of the six ecosystems monitored -14 out of 26 water samples and 27 out of 43 amphibian of in total 12 species- including three endangered toad species (Atelopus balios, A. nanay, and the rediscovered A. bomolochos). Our results highlight the potential of eDNA-based monitoring to assess the presence and prevalence of Bd in Ecuadorian aquatic ecosystems, in accordance with the National Action Plan for the Conservation of Ecuadorian Amphibians. Furthermore, our field lab approach leads to reliable and fast results for the monitoring of invasive species in a tropical context of a pandemic.
- Open Access
- 15 February 2021
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (1) , 1628-1636
Amphibian chytridiomycosis, a lethal pandemic disease caused by the killer fungus Batrachochytrium dendrobatidis: New approaches to host defense mechanisms and techniques for detection and monitoring
Chytridiomycosis is a catastrophic disease currently decimating worldwide amphibian populations, caused by the panzootic chytrid fungus Batrachochytrium dendrobatidis. Massive species decline to extinction catalyzes radical changes in ecosystems globally, including the largest continuous rainforest ecosystem on Earth, the Amazon rainforest. Innovative research that aims to propose feasible mechanisms of mitigation and the origins of the disease is vital, including studies addressing climatic effects on the expansion of chytridiomycosis. Thus, this publication aims to provide a comprehensive review of: i) the current technologies used for B. dendrobatidis detection and monitoring, and ii) the known Neotropical amphibian's skin microbiota with anti-fungal properties against B. dendrobatidis. Several immunologic and DNA-based methods are discussed to understand the emerging fungal pathogens and their effects on the biosphere, which can help to mitigate the devastating ecological impacts of mass amphibian morbidity. The establishment of rapid and highly accurate B. dendrobatidis detection techniques and methods for monitoring amphibian's cutaneous microbiome is crucial in the fight against chytridiomycosis.
- 15 February 2021
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (1) , 1628-1636
Open AccessAmphibian chytridiomycosis, a lethal pandemic disease caused by the killer fungus Batrachochytrium dendrobatidis: New approaches to host defense mechanisms and techniques for detection and monitoring
Chytridiomycosis is a catastrophic disease currently decimating worldwide amphibian populations, caused by the panzootic chytrid fungus Batrachochytrium dendrobatidis. Massive species decline to extinction catalyzes radical changes in ecosystems globally, including the largest continuous rainforest ecosystem on Earth, the Amazon rainforest. Innovative research that aims to propose feasible mechanisms of mitigation and the origins of the disease is vital, including studies addressing climatic effects on the expansion of chytridiomycosis. Thus, this publication aims to provide a comprehensive review of: i) the current technologies used for B. dendrobatidis detection and monitoring, and ii) the known Neotropical amphibian's skin microbiota with anti-fungal properties against B. dendrobatidis. Several immunologic and DNA-based methods are discussed to understand the emerging fungal pathogens and their effects on the biosphere, which can help to mitigate the devastating ecological impacts of mass amphibian morbidity. The establishment of rapid and highly accurate B. dendrobatidis detection techniques and methods for monitoring amphibian's cutaneous microbiome is crucial in the fight against chytridiomycosis.
- Open Access
- 15 February 2021
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (1) , 1637-1652
Bioproductos desarrollados a partir de micelio de hongos: Una nueva cultura material y su impacto en la transición hacia una economía sostenible
El biodiseño y biofabricación de biomateriales a partir de residuos vegetales lignocelulósicos y auto-generados por el micelio de hongos es un campo de investigación emergente desde las últimas dos décadas. Surge una nueva cultura material que se basa en los nuevos paradigmas de la fabricación alternativa partiendo de la lógica “de hacer crecer los nuevos materiales en lugar de extraerlos” e integrando los principios básicos de la economía circular y de la Biotecnología Material, asegurando la susceptibilidad de los mismos a ser biodegradados y volver a su estado original en la naturaleza. Su implementación a nivel industrial en distintas áreas de la manufactura comienza a competir con el cuero de origen animal, materiales y productos de origen petroquímico, a la vez que promueve nuevas alternativas de alimentos proteicos sustentables que contribuyan al cambio de los patrones de consumo humano de alto impacto ambiental arraigados a nivel global. La presente revisión, aborda una mirada particular que va desde lo molecular a lo global sobre la nueva cultura micelial, considerando aspectos generales del reino Fungi, la morfogénesis, composición química e integridad celular del micelio, los sistemas multienzimáticos extracelulares de degradación de lignocelulosa que poseen los hongos, pasando por los principales sustratos empleados, los biomateriales desarrollados a partir de micelio a nivel industrial, destacando los biotextiles, materiales y productos para el empaquetamiento y aislamiento, nuevas fuentes alimentarias basadas en el micelio, el arte y el diseño arquitectónico. Finalmente, se presenta el estado del arte actual de las empresas o laboratorios vanguardistas que suscitan una economía circular basada en el micelio de hongos a nivel mundial, al reemplazar recursos y productos de origen fósil por materiales amigables con el entorno, generando alternativas sostenibles y ciclos de producción con una baja demanda de energía y sin repercusiones al medio ambiente, es decir, promoviendo una nueva conciencia material.
- 15 February 2021
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (1) , 1637-1652
Open AccessBioproductos desarrollados a partir de micelio de hongos: Una nueva cultura material y su impacto en la transición hacia una economía sostenible
El biodiseño y biofabricación de biomateriales a partir de residuos vegetales lignocelulósicos y auto-generados por el micelio de hongos es un campo de investigación emergente desde las últimas dos décadas. Surge una nueva cultura material que se basa en los nuevos paradigmas de la fabricación alternativa partiendo de la lógica “de hacer crecer los nuevos materiales en lugar de extraerlos” e integrando los principios básicos de la economía circular y de la Biotecnología Material, asegurando la susceptibilidad de los mismos a ser biodegradados y volver a su estado original en la naturaleza. Su implementación a nivel industrial en distintas áreas de la manufactura comienza a competir con el cuero de origen animal, materiales y productos de origen petroquímico, a la vez que promueve nuevas alternativas de alimentos proteicos sustentables que contribuyan al cambio de los patrones de consumo humano de alto impacto ambiental arraigados a nivel global. La presente revisión, aborda una mirada particular que va desde lo molecular a lo global sobre la nueva cultura micelial, considerando aspectos generales del reino Fungi, la morfogénesis, composición química e integridad celular del micelio, los sistemas multienzimáticos extracelulares de degradación de lignocelulosa que poseen los hongos, pasando por los principales sustratos empleados, los biomateriales desarrollados a partir de micelio a nivel industrial, destacando los biotextiles, materiales y productos para el empaquetamiento y aislamiento, nuevas fuentes alimentarias basadas en el micelio, el arte y el diseño arquitectónico. Finalmente, se presenta el estado del arte actual de las empresas o laboratorios vanguardistas que suscitan una economía circular basada en el micelio de hongos a nivel mundial, al reemplazar recursos y productos de origen fósil por materiales amigables con el entorno, generando alternativas sostenibles y ciclos de producción con una baja demanda de energía y sin repercusiones al medio ambiente, es decir, promoviendo una nueva conciencia material.
- Open Access
- 15 February 2021
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (1) , 1593-1601
Genomic benchmarking studies reveal variations of the polyubiquitination domain of the PSD95 protein in Homo neanderthalensis and other primates of the Hominidae family: Possible implications in cognitive functions?
Modern humans' unique cognitive abilities regarding Neanderthals and other primate's lineages are frequently attributed to the differences in brain size development and evolution. However, recent studies have established the critical role of genomic and genetic benchmarking in analyzing the cognitive evolution between modern humans and primates, focused mainly on searching for involved genes in neurogenesis. PSD95 protein (named PSD95p) has a key role in modulating synaptic plasticity, learning, and memory skills. Thus, the present study aimed to determine the possible variations of the PSD95 gene between modern humans, Neanderthals, and other hominid primate species using bioinformatics tools. The results showed 14 polymorphisms compared with the contemporary human PSD95 gene, of which 13 were silent mutations, and only one was a non-silent mutation at the nucleotide position 281. Despite polymorphisms found at the nucleotide sequences, the PSD95p of humans and chimpanzees are 100% identical. Likewise, the gorilla and orangutan PSD95p are 100% identical, although a 103-amino acid deletion characterizes them at the N-terminal end (1-103), suggesting that it behaves like a non-functional protein. Interestingly, the single nucleotide polymorphism (SNP) found at position 281 in the Neanderthal PSD95 gene leads to a change of the E94 to valine V94 in the polyubiquitination domain (PEST) and variation in the three-dimensional structure of PSD95 protein. We prompt that this structural change in the PEST domain could induce a loss of PSD95p function and, therefore, an alteration in synaptic plasticity forms such as long-term potentiation (LTP) and long-term depression (LTD). These findings open a possible hypothesis supporting the idea that humans' cognitive evolution after separating our last common ancestor with Neanderthals lineage could have been accompanied by discrete changes in the PSD95p polyubiquitination domain.
- 15 February 2021
- Published by Clinical Biotec S.L. in Bionatura
- Vol. 6 (1) , 1593-1601
Open AccessGenomic benchmarking studies reveal variations of the polyubiquitination domain of the PSD95 protein in Homo neanderthalensis and other primates of the Hominidae family: Possible implications in cognitive functions?
Modern humans' unique cognitive abilities regarding Neanderthals and other primate's lineages are frequently attributed to the differences in brain size development and evolution. However, recent studies have established the critical role of genomic and genetic benchmarking in analyzing the cognitive evolution between modern humans and primates, focused mainly on searching for involved genes in neurogenesis. PSD95 protein (named PSD95p) has a key role in modulating synaptic plasticity, learning, and memory skills. Thus, the present study aimed to determine the possible variations of the PSD95 gene between modern humans, Neanderthals, and other hominid primate species using bioinformatics tools. The results showed 14 polymorphisms compared with the contemporary human PSD95 gene, of which 13 were silent mutations, and only one was a non-silent mutation at the nucleotide position 281. Despite polymorphisms found at the nucleotide sequences, the PSD95p of humans and chimpanzees are 100% identical. Likewise, the gorilla and orangutan PSD95p are 100% identical, although a 103-amino acid deletion characterizes them at the N-terminal end (1-103), suggesting that it behaves like a non-functional protein. Interestingly, the single nucleotide polymorphism (SNP) found at position 281 in the Neanderthal PSD95 gene leads to a change of the E94 to valine V94 in the polyubiquitination domain (PEST) and variation in the three-dimensional structure of PSD95 protein. We prompt that this structural change in the PEST domain could induce a loss of PSD95p function and, therefore, an alteration in synaptic plasticity forms such as long-term potentiation (LTP) and long-term depression (LTD). These findings open a possible hypothesis supporting the idea that humans' cognitive evolution after separating our last common ancestor with Neanderthals lineage could have been accompanied by discrete changes in the PSD95p polyubiquitination domain.
- Open Access
- 7 September 2020
- Published by ZappyLab, Inc.
3. GpVs production for encapsulating of the CRISPR/Cas13a RNPs complex and the APho-detection system (SYSTEM 1 and SYSTEM 2) v1
The selected cell line is constructed by transduction of human angiotensin I converting enzyme 2 (ACE2) into HEK-293T cells. This cell line is commercially available online by the following suppliers: Supplier Region Web Page Sino Biological USA, Europe, China https://www.sinobiological.com/lysates/human-ace2-10108-h05hl Innoprot Spain https://innoprot.com/es/product/ace2-cell-line Creative Biogen USA, Europe https://www.creative-biogene.com/ SYNTHEGO USA https://www.synthego.com/products/engineered-cells/pricing Creative diagnostics USA https://www.creative-diagnostics.com/news-human-ace2-stable-cell-line-hek293t-85.htm
- 7 September 2020
- Published by ZappyLab, Inc.
Open Access3. GpVs production for encapsulating of the CRISPR/Cas13a RNPs complex and the APho-detection system (SYSTEM 1 and SYSTEM 2) v1
The selected cell line is constructed by transduction of human angiotensin I converting enzyme 2 (ACE2) into HEK-293T cells. This cell line is commercially available online by the following suppliers: Supplier Region Web Page Sino Biological USA, Europe, China https://www.sinobiological.com/lysates/human-ace2-10108-h05hl Innoprot Spain https://innoprot.com/es/product/ace2-cell-line Creative Biogen USA, Europe https://www.creative-biogene.com/ SYNTHEGO USA https://www.synthego.com/products/engineered-cells/pricing Creative diagnostics USA https://www.creative-diagnostics.com/news-human-ace2-stable-cell-line-hek293t-85.htm
- Open Access
- 7 September 2020
- Published by ZappyLab, Inc.
1.Assembling of the CRISPR/Cas13a RNP complex (SYSTEM 1) v1
Cas13a from Leptotrichia wadeii (LwaCas13a) will be used for all experiments in this proposal. The LwaCas13a protein is not currently available commercially, but the LwaCas13a protein vector for expression can be found on Addgene (pC013-Twinstrep-SUMO-huLwCas13a, Plasmid #90097) in the Feng Zhang Lab Plasmids section (Gootenberg et al., 2017). A previously published production and purification protocols for LwaCas13a will be followed according to Gootenberg et al., (2017) with some modifications described by Iwasaki and Batey (2020). The pET28-APho plasmid is a vector constructed in our laboratory. The plasmids will be transformed into BL21(DE3) Rosetta Escherichia coli cells. The functional activity of LwaCas13a and APhoproteins will be assessed by a reliable fluorescence signal to detect the activity when Cas13a starts to exert its collateral RNAse activity. The restriction map of the pC013 plasmid and pET28-APho plasmid are shown in the following Figure: For the assembling of the RNP complex, Synthego recommends sgRNA:Cas9 ratios between 3:1 and 9:1 for RNP formation in trasnfection experiments. However, the SHERLOCK system recommends a sgRNA:Cas13a ratio of 1:1. We will start with the ratio recommended by SHERLOCK. References: Gootenberg J., Abudayyeh O. et al., (2017). Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 356, (6336): 438-442. doi:10.1126/science.aam9321 Iwasaki R and Batey R. (2020). SPRINT: a Cas13a-based platform for detection of small molecules Nucleic Acids Research, gkaa673. doi: 10.1093/nar/gkaa673.
- 7 September 2020
- Published by ZappyLab, Inc.
Open Access1.Assembling of the CRISPR/Cas13a RNP complex (SYSTEM 1) v1
Cas13a from Leptotrichia wadeii (LwaCas13a) will be used for all experiments in this proposal. The LwaCas13a protein is not currently available commercially, but the LwaCas13a protein vector for expression can be found on Addgene (pC013-Twinstrep-SUMO-huLwCas13a, Plasmid #90097) in the Feng Zhang Lab Plasmids section (Gootenberg et al., 2017). A previously published production and purification protocols for LwaCas13a will be followed according to Gootenberg et al., (2017) with some modifications described by Iwasaki and Batey (2020). The pET28-APho plasmid is a vector constructed in our laboratory. The plasmids will be transformed into BL21(DE3) Rosetta Escherichia coli cells. The functional activity of LwaCas13a and APhoproteins will be assessed by a reliable fluorescence signal to detect the activity when Cas13a starts to exert its collateral RNAse activity. The restriction map of the pC013 plasmid and pET28-APho plasmid are shown in the following Figure: For the assembling of the RNP complex, Synthego recommends sgRNA:Cas9 ratios between 3:1 and 9:1 for RNP formation in trasnfection experiments. However, the SHERLOCK system recommends a sgRNA:Cas13a ratio of 1:1. We will start with the ratio recommended by SHERLOCK. References: Gootenberg J., Abudayyeh O. et al., (2017). Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 356, (6336): 438-442. doi:10.1126/science.aam9321 Iwasaki R and Batey R. (2020). SPRINT: a Cas13a-based platform for detection of small molecules Nucleic Acids Research, gkaa673. doi: 10.1093/nar/gkaa673.
- Open Access
- 7 September 2020
- Published by ZappyLab, Inc.
2.Setup of the APho-detection system (SYSTEM 2) v1
Inactivation protocol for the Phosphatase Alkaline enzyme using RNA molecule. For the first time, an innovative detection system in CRISPR-based approaches is proposed at the present work that could revolutionize the recent efforts in biological engineering into the development of rapid COVID-19 diagnostics tests worldwide. In addition to its biotechnological interest, and because of its high sensitivity and selectivity, this proposal highlights the use of the Phosphatase Alkaline (APho) as a promising enzyme for nucleic acid detection in biological samples using CRISPR-based approaches. For the detection system, the APho will be inactivated by a short RNA oligonucleotide. Once the programmed CRISPR/Cas13a RNP complex targets the specific sequences in the SARS-CoV-2 genome (e.g., S and N structural encoding genes), it will activate its non-specific RNase activity releasing the inactivated-APho by collateral cleave of the RNA oligonucleotide. Later, the stable activated-APho enzyme will be able to react with the p-nitrophenyl phosphate (pNPP) substrate forming a yellow-colored product (p-nitrophenol) that is visible to the human eye and can be measured by a colorimetric device. In this proposal, we termed the APho-detection system as SYSTEM 2.
- 7 September 2020
- Published by ZappyLab, Inc.
Open Access2.Setup of the APho-detection system (SYSTEM 2) v1
Inactivation protocol for the Phosphatase Alkaline enzyme using RNA molecule. For the first time, an innovative detection system in CRISPR-based approaches is proposed at the present work that could revolutionize the recent efforts in biological engineering into the development of rapid COVID-19 diagnostics tests worldwide. In addition to its biotechnological interest, and because of its high sensitivity and selectivity, this proposal highlights the use of the Phosphatase Alkaline (APho) as a promising enzyme for nucleic acid detection in biological samples using CRISPR-based approaches. For the detection system, the APho will be inactivated by a short RNA oligonucleotide. Once the programmed CRISPR/Cas13a RNP complex targets the specific sequences in the SARS-CoV-2 genome (e.g., S and N structural encoding genes), it will activate its non-specific RNase activity releasing the inactivated-APho by collateral cleave of the RNA oligonucleotide. Later, the stable activated-APho enzyme will be able to react with the p-nitrophenyl phosphate (pNPP) substrate forming a yellow-colored product (p-nitrophenol) that is visible to the human eye and can be measured by a colorimetric device. In this proposal, we termed the APho-detection system as SYSTEM 2.
- Open Access
- 6 September 2020
- Published by ZappyLab, Inc.
5. Supporting the GpVs in hydrogel scaffolds v1
Supporting the Giant Cell-derived vesicles encapsulating systems 1 and 2
- 6 September 2020
- Published by ZappyLab, Inc.
Open Access5. Supporting the GpVs in hydrogel scaffolds v1
Supporting the Giant Cell-derived vesicles encapsulating systems 1 and 2
- Open Access
- 6 September 2020
- Published by ZappyLab, Inc.
4. Encapsulating CRISPR/Cas13a RNPs complex and the detection system in GpVs. v1
In addition to the innovative SARS-CoV-2 detection system by means APho enzymes, we propose an unprecedented design and construction of preassembled cell-derived Gigapack vesicles (termed GpV) with the stable overexpression of the hACE2 receptor, miming the SARS-CoV-2 infectious mechanisms and the virus-host interactions. GpV will be derived from the engineered hACE2 Stable Cell Line HEK-293, which is a human embryonic kidney cell line engineered to stable overexpression of hACE2. Cell line HEK-293 has been widely used in cell biology research for Spike SARS-CoV-2/hACE2 interaction studies and as a powerful tool for in vitro screening and characterization of potential drugs against SARS-CoV and SARS-Cov2. Inside of the GpV, both: i) a CRISPR/Cas13a-based nucleic-acid recognition system (SYSTEM 1), and ii) an APho-detection system (SYSTEM 2), will be encapsulated. Encapsulation of the CRISPR/Cas13a RNP complex (SYSTEM 1) and APho-detection system including its substrate (SYSTEM 2) will be performed by electroporation. We will use the guidelines given for the Neon transfection system (Invitrogen, ThermoFisher). The Neon transfection protocol is recommended for SYNTHEGO to deliver ribonucleoprotein (RNP) complexes that consist of purified Cas9 nuclease duplexed with chemically modified synthetic single-guide RNA (sgRNA) to immortalized adherent or suspension cells (https://www.synthego.com/resources/immortalized-cell-neon-electroporation-protocol).
- 6 September 2020
- Published by ZappyLab, Inc.
Open Access4. Encapsulating CRISPR/Cas13a RNPs complex and the detection system in GpVs. v1
In addition to the innovative SARS-CoV-2 detection system by means APho enzymes, we propose an unprecedented design and construction of preassembled cell-derived Gigapack vesicles (termed GpV) with the stable overexpression of the hACE2 receptor, miming the SARS-CoV-2 infectious mechanisms and the virus-host interactions. GpV will be derived from the engineered hACE2 Stable Cell Line HEK-293, which is a human embryonic kidney cell line engineered to stable overexpression of hACE2. Cell line HEK-293 has been widely used in cell biology research for Spike SARS-CoV-2/hACE2 interaction studies and as a powerful tool for in vitro screening and characterization of potential drugs against SARS-CoV and SARS-Cov2. Inside of the GpV, both: i) a CRISPR/Cas13a-based nucleic-acid recognition system (SYSTEM 1), and ii) an APho-detection system (SYSTEM 2), will be encapsulated. Encapsulation of the CRISPR/Cas13a RNP complex (SYSTEM 1) and APho-detection system including its substrate (SYSTEM 2) will be performed by electroporation. We will use the guidelines given for the Neon transfection system (Invitrogen, ThermoFisher). The Neon transfection protocol is recommended for SYNTHEGO to deliver ribonucleoprotein (RNP) complexes that consist of purified Cas9 nuclease duplexed with chemically modified synthetic single-guide RNA (sgRNA) to immortalized adherent or suspension cells (https://www.synthego.com/resources/immortalized-cell-neon-electroporation-protocol).